Matching slides 18,554
Current window 2,521-2,550
Pages 619
Rows per page 30
Component: Quoteclear collectionreset all

Component

2,521-2,550 of 18,554

filter-aware
117
Uses testimonial-style quotes from KOLs to build a case of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
118
The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
119
The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
121
Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
138
Uses direct quotes from KOLs to undermine the company's product launch narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
139
The slide uses direct quotes from a former executive to undermine management's credibility and the product's market viability.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
142
Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
143
Uses testimonial-style quotes from a competitor's regional sales manager to undermine the target company's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
149
Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
150
Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
151
Uses expert quotes to undermine the company's core product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
152
Uses KOL testimonials to highlight a technical contradiction in the company's product claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
159
Uses expert quotes to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
160
Uses expert testimony (KOLs) to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
161
The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
164
Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
168
The slide uses direct quotes from KOLs to undermine the company's technical claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
170
The slide uses a 'quote-sandwich' structure to validate the thesis headline.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
171
Uses expert testimony to contradict company growth narratives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
174
Features highlighted text blocks in yellow to emphasize critical quotes from former executives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
175
Uses expert testimony to frame the company's situation as dire.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
176
Uses expert testimony to undermine management credibility and highlight operational failures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
178
Uses expert testimony to undermine the investment thesis of a turnaround.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
182
The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
183
Uses expert testimony to debunk market optimism regarding M&A.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
188
The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
191
The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
194
The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
195
Uses expert testimony to frame the company's pricing strategy as a terminal failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits